Metformin Ameliorates Podocyte Damage by Restoring Renal Tissue Podocalyxin Expression in Type 2 Diabetic Rats
Podocalyxin (PCX) is a signature molecule of the glomerular podocyte and of maintaining integrity of filtration function of glomerulus. The aim of this study was to observe the effect of different doses of metformin on renal tissue PCX expression in type 2 diabetic rats and clarify its protection on...
Saved in:
Main Authors: | , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2015-01-01
|
Series: | Journal of Diabetes Research |
Online Access: | http://dx.doi.org/10.1155/2015/231825 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
_version_ | 1832567698134925312 |
---|---|
author | Limin Zhai Junfei Gu Di Yang Wei Wang Shandong Ye |
author_facet | Limin Zhai Junfei Gu Di Yang Wei Wang Shandong Ye |
author_sort | Limin Zhai |
collection | DOAJ |
description | Podocalyxin (PCX) is a signature molecule of the glomerular podocyte and of maintaining integrity of filtration function of glomerulus. The aim of this study was to observe the effect of different doses of metformin on renal tissue PCX expression in type 2 diabetic rats and clarify its protection on glomerular podocytes. Type 2 diabetic Sprague-Dawley (SD) rats in which diabetes was induced by high-fat diet/streptozotocin (HFD-STZ) were treated with different doses of metformin (150, 300, and 500 mg/kg per day, resp.) for 8 weeks. Various biochemical parameters, kidney histopathology, and renal tissue PCX expression levels were examined. In type 2 diabetic rats, severe hyperglycemia and hyperlipidemia were developed. Urinary albumin and PCX were markedly increased. Diabetes induced significant alterations in renal glomerular structure. In addition, protein and mRNA expression of renal tissue PCX were highly decreased. However, treatment of rats with different doses of metformin restored all these changes to a varying degree. These results suggested that metformin can ameliorate glomerular podocyte damage in type 2 diabetic rats, which may be partly associated with its role in restoring PCX expression and inhibiting urinary excretion of PCX with dose dependence. |
format | Article |
id | doaj-art-fc4cde9a8e49434bb039d809f2c5b408 |
institution | Kabale University |
issn | 2314-6745 2314-6753 |
language | English |
publishDate | 2015-01-01 |
publisher | Wiley |
record_format | Article |
series | Journal of Diabetes Research |
spelling | doaj-art-fc4cde9a8e49434bb039d809f2c5b4082025-02-03T01:00:54ZengWileyJournal of Diabetes Research2314-67452314-67532015-01-01201510.1155/2015/231825231825Metformin Ameliorates Podocyte Damage by Restoring Renal Tissue Podocalyxin Expression in Type 2 Diabetic RatsLimin Zhai0Junfei Gu1Di Yang2Wei Wang3Shandong Ye4Department of Endocrinology, Anhui Provincial Hospital Affiliated to Anhui Medical University, Hefei 230001, ChinaDepartment of Endocrinology, Anhui Provincial Hospital Affiliated to Anhui Medical University, Hefei 230001, ChinaDepartment of Endocrinology, Anhui Provincial Hospital Affiliated to Anhui Medical University, Hefei 230001, ChinaDepartment of Endocrinology, Anhui Provincial Hospital Affiliated to Anhui Medical University, Hefei 230001, ChinaDepartment of Endocrinology, Anhui Provincial Hospital Affiliated to Anhui Medical University, Hefei 230001, ChinaPodocalyxin (PCX) is a signature molecule of the glomerular podocyte and of maintaining integrity of filtration function of glomerulus. The aim of this study was to observe the effect of different doses of metformin on renal tissue PCX expression in type 2 diabetic rats and clarify its protection on glomerular podocytes. Type 2 diabetic Sprague-Dawley (SD) rats in which diabetes was induced by high-fat diet/streptozotocin (HFD-STZ) were treated with different doses of metformin (150, 300, and 500 mg/kg per day, resp.) for 8 weeks. Various biochemical parameters, kidney histopathology, and renal tissue PCX expression levels were examined. In type 2 diabetic rats, severe hyperglycemia and hyperlipidemia were developed. Urinary albumin and PCX were markedly increased. Diabetes induced significant alterations in renal glomerular structure. In addition, protein and mRNA expression of renal tissue PCX were highly decreased. However, treatment of rats with different doses of metformin restored all these changes to a varying degree. These results suggested that metformin can ameliorate glomerular podocyte damage in type 2 diabetic rats, which may be partly associated with its role in restoring PCX expression and inhibiting urinary excretion of PCX with dose dependence.http://dx.doi.org/10.1155/2015/231825 |
spellingShingle | Limin Zhai Junfei Gu Di Yang Wei Wang Shandong Ye Metformin Ameliorates Podocyte Damage by Restoring Renal Tissue Podocalyxin Expression in Type 2 Diabetic Rats Journal of Diabetes Research |
title | Metformin Ameliorates Podocyte Damage by Restoring Renal Tissue Podocalyxin Expression in Type 2 Diabetic Rats |
title_full | Metformin Ameliorates Podocyte Damage by Restoring Renal Tissue Podocalyxin Expression in Type 2 Diabetic Rats |
title_fullStr | Metformin Ameliorates Podocyte Damage by Restoring Renal Tissue Podocalyxin Expression in Type 2 Diabetic Rats |
title_full_unstemmed | Metformin Ameliorates Podocyte Damage by Restoring Renal Tissue Podocalyxin Expression in Type 2 Diabetic Rats |
title_short | Metformin Ameliorates Podocyte Damage by Restoring Renal Tissue Podocalyxin Expression in Type 2 Diabetic Rats |
title_sort | metformin ameliorates podocyte damage by restoring renal tissue podocalyxin expression in type 2 diabetic rats |
url | http://dx.doi.org/10.1155/2015/231825 |
work_keys_str_mv | AT liminzhai metforminamelioratespodocytedamagebyrestoringrenaltissuepodocalyxinexpressionintype2diabeticrats AT junfeigu metforminamelioratespodocytedamagebyrestoringrenaltissuepodocalyxinexpressionintype2diabeticrats AT diyang metforminamelioratespodocytedamagebyrestoringrenaltissuepodocalyxinexpressionintype2diabeticrats AT weiwang metforminamelioratespodocytedamagebyrestoringrenaltissuepodocalyxinexpressionintype2diabeticrats AT shandongye metforminamelioratespodocytedamagebyrestoringrenaltissuepodocalyxinexpressionintype2diabeticrats |